Eosinophilic Gastroenteritis
18
3
4
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
16.7%
3 terminated out of 18 trials
78.6%
-8.0% vs benchmark
22%
4 trials in Phase 3/4
64%
7 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 11 completed trials
Clinical Trials (18)
A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
Eosinophilic Gastrointestinal Disorders Registry
Dupilumab in Eosinophilic Gastritis
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eosinophilic Gastroenteritis
Examining the Effect of Ondansetron on Bowel Prep Success
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis
A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis
A Study of Lirentelimab (AK002) in Patients With Active Eosinophilic Duodenitis
Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Effect of Elemental Diet on Adult Patients With Eosinophilic Gastroenteritis
Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome
Sirolimus for Eosinophil-Associated Gastrointestinal Disorders
Immunopathogenesis of Food Allergy and Eosinophilic Gastrointestinal Disorders
Data Bank for Eosinophilic Disorders
Montelukast in the Treatment of Duodenal Eosinophilia